SEC Form 4 · accession 0001144204-17-064824
Synthetic Biologics, Inc. · SYN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Tarriff
Director
Period of report
Dec 20, 2017
Accepted (ET)
Dec 21, 2017 · 5:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000894158
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $0.52 | Dec 20, 2017 | A | 200,000 | A | Dec 20, 2018 | Dec 19, 2024 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1These stock options vest in full on the one year anniversary of the grant date.